Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial

The potential antitumoural effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) led us to evaluate GM-CSF alone or with dacarbazine (DTIC) in metastatic melanoma in first line randomized phase II. Treatment was arm A: GM-CSF: 5 μg kg(−1), bid, 14 consecutive days every 21 days and arm...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ravaud, A, Delaunay, M, Chevreau, C, Coulon, V, Debled, M, Bret-Dibat, C, Courbon, F, Gualde, N, Bui, B Nguyen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2001
Konular:
Regular Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363949/
https://ncbi.nlm.nih.gov/pubmed/11720430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2120
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller